Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
BioGenerator Ventures, established in 2004, operates from St. Louis, Missouri, as the investment arm of BioSTL, a regional bioeconomy development organization. The firm focuses on early-stage investments in life sciences and agriculture technology, aiming to attract outside capital to support local bioscience companies. This unique positioning allows BioGenerator Ventures to play a pivotal role in fostering innovation and growth within the sector.
As of 2025, BioGenerator Ventures has deployed approximately $44 million across more than 130 companies, showcasing its commitment to the growth of the bioscience ecosystem. The firm has facilitated the raising of over $2.8 billion by its portfolio companies, indicating a strong track record of attracting follow-on investments. BioGenerator Ventures operates with a team of experienced professionals dedicated to supporting startups through various stages of development.
Headquartered in St. Louis, the firm has become a key player in the U.S. biotech and healthcare markets, leveraging its extensive network and resources to enhance the potential of its portfolio companies. The firm’s notable milestones include successful exits such as Benson Hill, which went public in a $2 billion SPAC merger, and the acquisition of CoverCress by Bayer AG.
BioGenerator Ventures specializes in early-stage investments across several sectors, including healthcare, biotech, and agtech. The firm primarily targets companies involved in therapeutics, diagnostics, medical devices, research tools, and agricultural technology. Their investment strategy employs a staged approach, providing increasing amounts of capital as companies reach specific milestones, which helps mitigate risk and supports growth.
The firm actively syndicates deals with other venture capital firms globally, enhancing the potential for follow-on funding and strategic partnerships. BioGenerator Ventures seeks to invest in companies that address significant challenges in human health and agriculture, acting as a catalytic force to attract outside capital into St. Louis-based bioscience companies. They value founders who demonstrate a strong vision and commitment to their mission, as well as those who are open to collaboration and mentorship.
BioGenerator Ventures boasts a diverse portfolio of over 80 active investments, including notable companies such as:
Additionally, the firm has achieved notable exits, including:
BioGenerator Ventures continues to expand its portfolio, actively investing in startups that align with its mission to drive innovation in life sciences and agriculture.
Jim McCarter - Senior Managing Director. Jim has been with BioGenerator Ventures since its inception and has played a crucial role in shaping its investment strategy. He has extensive experience in venture capital and has led numerous successful investments in the life sciences sector.
Allyson Mayer - Principal. Allyson focuses on sourcing and evaluating new investment opportunities, particularly in the healthcare and biotech sectors. She has a strong background in life sciences and has previously worked with several startups in various capacities.
Ann Guggisberg - Principal. Ann specializes in early-stage investments and has a keen interest in agricultural technology. She has a background in both venture capital and operational roles within startups.
Kari Miller - Senior Associate. Kari supports the investment team in due diligence and portfolio management, bringing her analytical skills and experience in the biotech industry.
Alec Beeve - Senior Associate. Alec focuses on identifying promising startups and conducting market research to support investment decisions. He has a strong interest in healthcare innovation.
Alex Andrews - Senior Associate. Alex assists in evaluating investment opportunities and managing relationships with portfolio companies, leveraging his background in life sciences.
Christy Althaber - Lab Manager. Christy oversees the operations of BioGenerator Labs, ensuring that portfolio companies have access to the necessary resources and support.
Mike Davies - BioGenerator Labs at Helix. Mike plays a key role in supporting startups within the lab environment, providing guidance and resources to help them succeed.
AJ Habicht - Event Coordinator and Administrative Assistant. AJ manages events and administrative tasks, contributing to the overall efficiency of the organization.
To pitch BioGenerator Ventures, founders should visit their website at biogeneratorventures.com and submit their pitch through the contact form or via email at info@biogeneratorventures.com. A comprehensive pitch deck should include information about the startup's mission, market opportunity, competitive landscape, and financial projections.
BioGenerator Ventures prefers to receive pitches that clearly outline the startup's unique value proposition and any traction achieved to date. Founders should expect a response within a few weeks, and while warm introductions are appreciated, they are not strictly necessary.
BioGenerator Labs offers various resources to support startups, including coaching from experienced Executives in Residence, access to collaborative lab and office space, and state-of-the-art equipment. The lab also provides non-dilutive grants for early de-risking activities, with awards ranging from a few thousand dollars to over $50,000.
Additionally, BioGenerator Ventures hosts the **Innovators Hour**, a series aimed at fostering community engagement and support for startups through storytelling by innovators in the St. Louis area.
In 2024, BioGenerator Ventures invested $3.3 million across 18 companies, demonstrating its active engagement in the startup ecosystem. This investment activity highlights the firm's commitment to supporting early-stage life sciences and agtech companies.
Recent notable portfolio developments include Geneoscopy's successful Series B funding round, which BioGenerator Ventures co-led, and the continued growth of Benson Hill following its public listing. The firm has also been recognized for its role in facilitating significant follow-on capital for its portfolio companies, with over $2.8 billion raised to date.
What are BioGenerator Ventures' investment criteria?
BioGenerator Ventures focuses on early-stage life sciences companies, particularly in therapeutics, diagnostics, medical devices, research tools, and agriculture technology. They look for companies that address significant challenges in human health and agriculture.
How can I apply or pitch to BioGenerator Ventures?
Founders can pitch their ideas by visiting the BioGenerator Ventures website at biogeneratorventures.com and submitting their information through the contact form or by emailing info@biogeneratorventures.com. A well-prepared pitch deck should include details about the business model, market opportunity, and team.
What makes BioGenerator Ventures different from other investors?
BioGenerator Ventures operates as the investment arm of BioSTL, which allows them to provide unique resources such as access to BioGenerator Labs, coaching from experienced Executives in Residence, and connections to other investors. This model enhances their ability to support portfolio companies beyond just capital.
What is the geographic scope of BioGenerator Ventures?
The firm primarily invests in companies based in the United States, with a strong focus on those located in or willing to relocate to St. Louis, Missouri. They aim to attract outside capital to support local bioscience companies.
What is the typical check size for investments?
BioGenerator Ventures employs a staged investment approach, providing increasing amounts of capital as companies reach specific milestones. While specific check sizes are not disclosed, they are known for their catalytic investments that help attract additional funding.
What kind of post-investment involvement does BioGenerator Ventures have?
BioGenerator Ventures actively supports its portfolio companies through mentorship, access to resources at BioGenerator Labs, and assistance in securing follow-on funding. They often involve themselves in the strategic direction of the companies they invest in.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.